Bambusa Therapeutics
$40.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 31, 2025 | Early Stage VC (Series A2) | $40.0M | N/A | - |
| February 12, 2025 | Early Stage VC (Series A) | $88.9M | N/A | - |
Current Valuation Metrics
Bambusa Therapeutics is currently valued at $555.0M as of October 31, 2025. The company has raised a total of $143.0M in funding across 2 funding rounds.
Capital Efficiency
With a capital efficiency ratio of 3.88x, Bambusa Therapeutics has achieved a valuation that is 3.88 times the total capital raised.
What is Bambusa Therapeutics Worth in 2026?
Bambusa Therapeutics is a leading private company in the Drug Discovery sector. Track Bambusa Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Bambusa Therapeutics Valuation is Determined
Private company valuations like Bambusa Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.